In another study on breast cancer, it was found that PTP4A3 can induce the transformation of normal cancer cells into stem-like cells by competitively binding to MEF2A with HDAC4 (histone deacetylase 4), a process independent of PTP4A3’s phosphatase activity. Here, MEF2A is linked to cancer.